Paroxysmal nocturnal hemoglobinuria: Where are we going |
May 2023 |
American Journal of Hematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Myelodysplastic Syndromes: 2021 update on Diagnosis, Risk-stratification and Management |
Aug 2020 |
American Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
Clinical decision-making and treatment of myelodysplastic syndromes |
Dec 2023 |
American Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
Iron overload after complement inhibitor treatment of Paroxysmal Nocturnal Hemoglobinuria |
Apr 2021 |
American Journal of Hematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Real-world experience of pegcetacoplan in paroxysmal nocturnal hemoglobinuria |
May 2021 |
American Journal of Hematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes |
Nov 2019 |
American Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties |
Jun 2024 |
American Journal of Hematology |
Aplastic Anemia |
Alemtuzumab in relapsed immune severe aplastic anemia: Long-term results of a phase II study |
Jun 2023 |
American Journal of Hematology |
Aplastic Anemia |
Alemtuzumab in relapsed immune severe aplastic anemia: Long-term results of a phase II study |
Apr 2023 |
American Journal of Hematology |
Aplastic Anemia |
Patients with paroxysmal nocturnal hemoglobinuria demonstrate a prothrombotic clotting phenotype which is improved by complement inhibition with eculizumab |
Aug 2020 |
American Journal of Hematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |